282 related articles for article (PubMed ID: 34064774)
1. Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance.
Rhee SY; Tzou PL; Shafer RW
Viruses; 2021 May; 13(5):. PubMed ID: 34064774
[TBL] [Abstract][Full Text] [Related]
2. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
3. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
4. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
Rhee SY; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; Rinke de Wit TF; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CA; Brumme ZL; Busch MP; Bussmann H; Chaix ML; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Ng KP; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Terán G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong HM; van de Vijver DA; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JP; Vandamme AM; Shafer RW
PLoS Med; 2015 Apr; 12(4):e1001810. PubMed ID: 25849352
[TBL] [Abstract][Full Text] [Related]
5. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance.
Rhee SY; Schapiro JM; Saladini F; Zazzi M; Khoo S; Shafer RW
AIDS Res Ther; 2023 Feb; 20(1):8. PubMed ID: 36750835
[TBL] [Abstract][Full Text] [Related]
6. Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012-2020).
Alexiev I; Shankar A; Pan Y; Grigorova L; Partsuneva A; Dimitrova R; Gancheva A; Kostadinova A; Elenkov I; Yancheva N; Grozdeva R; Strashimirov D; Stoycheva M; Baltadzhiev I; Doichinova T; Pekova L; Kosmidis M; Emilova R; Nikolova M; Switzer WM
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112921
[TBL] [Abstract][Full Text] [Related]
7. From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.
Namakoola I; Kasamba I; Mayanja BN; Kazooba P; Lutaakome J; Lyagoba F; Kapaata AA; Kaleebu P; Munderi P;
BMC Res Notes; 2016 Dec; 9(1):515. PubMed ID: 28010730
[TBL] [Abstract][Full Text] [Related]
8. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
Moyo S; Gaseitsiwe S; Zahralban-Steele M; Maruapula D; Nkhisang T; Mokaleng B; Mohammed T; Ditlhako TR; Bareng OT; Mokgethi TP; van Widenfelt E; Pretorius-Holme M; Mine MO; Raizes E; Yankinda EK; Wirth KE; Gaolathe T; Makhema JM; Lockman S; Essex M; Novitsky V
AIDS; 2019 May; 33(6):1073-1082. PubMed ID: 30946161
[TBL] [Abstract][Full Text] [Related]
9. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.
Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962
[TBL] [Abstract][Full Text] [Related]
10. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
Ross LL; Shortino D; Shaefer MS
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
[TBL] [Abstract][Full Text] [Related]
11. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007.
Hurt CB; McCoy SI; Kuruc J; Nelson JA; Kerkau M; Fiscus S; McGee K; Sebastian J; Leone P; Pilcher C; Hicks C; Eron J
Antivir Ther; 2009; 14(5):673-8. PubMed ID: 19704170
[TBL] [Abstract][Full Text] [Related]
12. Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.
Myers JE; Taylor BS; Rojas Fermín RA; Reyes EV; Vaughan C; José L; Javier C; Franco Estévez R; Donastorg Cabral Y; Batista A; Lie Y; Coakley E; Hammer SM; Brudney K
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):667-74. PubMed ID: 21851324
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G
Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416
[TBL] [Abstract][Full Text] [Related]
14. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Viñuela L; de Salazar A; Fuentes A; Serrano-Conde E; Falces-Romero I; Pinto A; Portilla I; Masiá M; Peraire J; Gómez-Sirvent JL; Sanchiz M; Iborra A; Baza B; Aguilera A; Olalla J; Espinosa N; Iribarren JA; Martínez-Velasco M; Imaz A; Montero M; Rivero M; Suarez-García I; Maciá MD; Galán JC; Perez-Elias MJ; García-Fraile LJ; Moreno C; Garcia F
J Med Virol; 2023 Dec; 95(12):e29287. PubMed ID: 38084763
[TBL] [Abstract][Full Text] [Related]
15. [Resistance profile of rilpivirine].
Imaz A; García F; di Yacovo S; Llibre JM
Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():36-43. PubMed ID: 24252532
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HIV drug resistance mutation in the northern Indian population after failure of the first line antiretroviral therapy.
Sinha S; Shekhar RC; Ahmad H; Kumar N; Samantaray JC; Sreenivas V; Khan NH; Mitsuyasu RT
Curr HIV Res; 2012 Sep; 10(6):532-8. PubMed ID: 22716105
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.
Kirichenko A; Kireev D; Lapovok I; Shlykova A; Lopatukhin A; Pokrovskaya A; Bobkova M; Antonova A; Kuznetsova A; Ozhmegova E; Shtrek S; Sannikov A; Zaytseva N; Peksheva O; Piterskiy M; Semenov A; Turbina G; Filoniuk N; Shemshura A; Kulagin V; Kolpakov D; Suladze A; Kotova V; Balakhontseva L; Pokrovsky V; Akimkin V
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112971
[TBL] [Abstract][Full Text] [Related]
18. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
19. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Åsjö B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Staneková D; Stanojevic M; Van Laethem K; Zazzi M; Zidovec Lepej S; Boucher CAB; Schmit JC; Wensing AMJ; ; Puchhammer-Stockl E; Sarcletti M; Schmied B; Geit M; Balluch G; Vandamme AM; Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; Vandekerckhove LPR; Van den Heuvel A; Van Der Gucht B; Van Ranst M; Van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Van Laethem K; Beshkov D; Alexiev I; Lepej SZ; Begovac J; Kostrikis L; Demetriades I; Kousiappa I; Demetriou V; Hezka J; Linka M; Maly M; Machala L; Nielsen C; Jørgensen LB; Gerstoft J; Mathiesen L; Pedersen C; Nielsen H; Laursen A; Kvinesdal B; Liitsola K; Ristola M; Suni J; Sutinen J; Descamps D; Assoumou L; Castor G; Grude M; Flandre P; Storto A; Hamouda O; Kücherer C; Berg T; Braun P; Poggensee G; Däumer M; Eberle J; Heiken H; Kaiser R; Knechten H; Korn K; Müller H; Neifer S; Schmidt B; Walter H; Gunsenheimer-Bartmeyer B; Harrer T; Paraskevis D; Hatzakis A; Zavitsanou A; Vassilakis A; Lazanas M; Chini M; Lioni A; Sakka V; Kourkounti S; Paparizos V; Antoniadou A; Papadopoulos A; Poulakou G; Katsarolis I; Protopapas K; Chryssos G; Drimis S; Gargalianos P; Xylomenos G; Lourida G; Psichogiou M; Daikos GL; Sipsas NV; Kontos A; Gamaletsou MN; Koratzanis G; Sambatakou H; Mariolis H; Skoutelis A; Papastamopoulos V; Georgiou O; Panagopoulos P; Maltezos E; Coughlan S; De Gascun C; Byrne C; Duffy M; Bergin C; Reidy D; Farrell G; Lambert J; O'Connor E; Rochford A; Low J; Coakely P; O'Dea S; Hall W; Mor O; Levi I; Chemtob D; Grossman Z; Zazzi M; de Luca A; Balotta C; Riva C; Mussini C; Caramma I; Capetti A; Colombo MC; Rossi C; Prati F; Tramuto F; Vitale F; Ciccozzi M; Angarano G; Rezza G; Kolupajeva T; Vasins O; Griskevicius A; Lipnickiene V; Schmit JC; Struck D; Sauvageot N; Hemmer R; Arendt V; Michaux C; Staub T; Sequin-Devaux C; Wensing AMJ; Boucher CAB; van de Vijver DAMC; van Kessel A; van Bentum PHM; Brinkman K; Connell BJ; van der Ende ME; Hoepelman IM; van Kasteren M; Kuipers M; Langebeek N; Richter C; Santegoets RMWJ; Schrijnders-Gudde L; Schuurman R; van de Ven BJM; Åsjö B; Kran AB; Ormaasen V; Aavitsland P; Horban A; Stanczak JJ; Stanczak GP; Firlag-Burkacka E; Wiercinska-Drapalo A; Jablonowska E; Maolepsza E; Leszczyszyn-Pynka M; Szata W; Camacho R; Palma C; Borges F; Paixão T; Duque V; Araújo F; Otelea D; Paraschiv S; Tudor AM; Cernat R; Chiriac C; Dumitrescu F; Prisecariu LJ; Stanojevic M; Jevtovic D; Salemovic D; Stanekova D; Habekova M; Chabadová Z; Drobkova T; Bukovinova P; Shunnar A; Truska P; Poljak M; Lunar M; Babic D; Tomazic J; Vidmar L; Vovko T; Karner P; Garcia F; Paredes R; Monge S; Moreno S; Del Amo J; Asensi V; Sirvent JL; de Mendoza C; Delgado R; Gutiérrez F; Berenguer J; Garcia-Bujalance S; Stella N; de Los Santos I; Blanco JR; Dalmau D; Rivero M; Segura F; Elías MJP; Alvarez M; Chueca N; Rodríguez-Martín C; Vidal C; Palomares JC; Viciana I; Viciana P; Cordoba J; Aguilera A; Domingo P; Galindo MJ; Miralles C; Del Pozo MA; Ribera E; Iribarren JA; Ruiz L; de la Torre J; Vidal F; Clotet B; Albert J; Heidarian A; Aperia-Peipke K; Axelsson M; Mild M; Karlsson A; Sönnerborg A; Thalme A; Navér L; Bratt G; Karlsson A; Blaxhult A; Gisslén M; Svennerholm B; Bergbrant I; Björkman P; Säll C; Mellgren Å; Lindholm A; Kuylenstierna N; Montelius R; Azimi F; Johansson B; Carlsson M; Johansson E; Ljungberg B; Ekvall H; Strand A; Mäkitalo S; Öberg S; Holmblad P; Höfer M; Holmberg H; Josefson P; Ryding U
Clin Infect Dis; 2016 Mar; 62(5):655-663. PubMed ID: 26620652
[TBL] [Abstract][Full Text] [Related]
20. The Frequency of HIV-1 Infection in Iranian Children and Determination of the Transmitted Drug Resistance in Treatment-Naïve Children.
Jarchi M; Bokharaei-Salim F; Esghaei M; Kiani SJ; Jahanbakhsh F; Monavari SH; Ataei-Pirkooh A; Marjani A; Keyvani H
Curr HIV Res; 2019; 17(6):397-407. PubMed ID: 31702525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
